We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
REVIEW
Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
Seminars in Oncology 1999 October
Many patients with stage I-IIIA non-small cell lung cancer (NSCLC) resected for cure will experience distant relapse. Results of adjuvant chemotherapy trials after surgery have generally been negative. Neoadjuvant or induction chemotherapy before surgery offers several theoretical advantages; the results of neoadjuvant chemotherapy or combined chemoradiation therapy followed by surgery in resectable and potentially resectable NSCLC are reviewed in this report. In resectable NSCLC, the results of two small trials have yielded positive trends in favor of neoadjuvant chemotherapy. However, neither of these trials was flawless; therefore, firm conclusions cannot yet be drawn. In selected patients with initially nonresectable NSCLC, several phase II studies have demonstrated the potential utility of induction chemotherapy or combined chemoradiation therapy. A relatively high proportion of these patients were rendered resectable. Pathologic complete remissions were observed in up to 25% of patients and survival rates improved significantly, particularly in patients achieving pathologic complete remission. A current intergroup trial will ultimately assess the utility of surgery after induction chemoradiation in this group of patients. The advent of newer agents with demonstrated activity in advanced NSCLC has led to the design of potentially more effective but also more toxic neoadjuvant regimens. Some of these are under investigation in large randomized phase III trials, which should ultimately elucidate the role of induction therapy with "modern" agents in potentially curable NSCLC.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app